Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07585032
Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma
Sponsor: Sahlgrenska University Hospital
View on ClinicalTrials.gov
Summary
Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.
Key Details
Gender
All
Age Range
15 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2025-03-31
Completion Date
2029-06
Last Updated
2026-05-13
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
EUS-RFA
Treatment of insulinoma by EUS-RFA
Locations (1)
Sahlgrenska Univeristy Hospital
Gothenburg, Sweden